ArticleLeukemia2005
Fusion of NUP214 to ABL1 on amplified episomes in T-ALL--implications for treatment.
Article in Leukemia, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1-new finding in erythroblastic sarcoma/acute erythroid leukemia.Journal of hematopathology · 2026Article
- Clinical, Phenotypic and Molecular Characterization ofJournal of medical cases · 2024Article
- Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a CrypticPathology oncology research : POR · 2022Article
- Case Report: The First Report ofFrontiers in oncology · 2021Article
- European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.Leukemia · 2019Review
- Cell-Free eccDNAs: A New Type of Nucleic Acid Component for Liquid Biopsy?Molecular diagnosis & therapy · 2018Review
- Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic Leukemia.Cancer cell · 2018Article
- Unique amplification of BCR-ABL1 gene fusion in a case of T-cell acute lymphoblastic leukemia.Molecular cytogenetics · 2017Article
- NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.Haematologica · 2016Article
- Article
- Characterization of KRAS rearrangements in metastatic prostate cancer.Cancer discovery · 2011Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
16015385What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.